Article
Genetically Engineered Cell Membrane-Coated Nanodrug for Targeted Treatment of Thyroid Cancer
2025-10-15
Abstract excerpt
Thyroid cancer is the most common endocrine malignancy, particularly in patients with radioactive iodine-refractory differentiated thyroid cancer (RAIR-DTC), who have limited treatment options and poor clinical prognosis. In this study, doxorubicin (DOX) and sorafenib (SOR) were loaded into the photothermal conversion agent mesoporous polydopamine (mPDA), forming mPDS. Tumor cell membrane coating engineering resul...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 391713b2-8311-565b-ba8e-96a38ba44ca2
- DOI
- 10.1101/2025.10.15.682623
